Ketonia $KTN
Ketonia licenses a longitudinal, consent-registered clinical database of fully tracked metabolic-health patients to pharma, Health-AI teams, payers and DeSci DAOs. Access is priced, paid for and governed in $KTN.
The asset: a longitudinal clinical reserve
Ketonia has operated a functional-medicine platform for reversing metabolic disease (primarily Type 2 Diabetes) through lifestyle intervention for about four years. Its decisive, non-replicable asset is not its brand or its token — it is a structured, longitudinal clinical database: 1,700+ complete records of fully tracked patients spanning multi-year metabolic trajectories.
What each record contains
- HbA1c series over multiple years
- Medication & insulin tapering histories
- Fasting and ketogenic protocol adherence
- Anthropometrics and lab panels
- Documented intervention → outcome pairs
Why it is scarce
Cross-sectional datasets are commoditized. Multi-year per-patient trajectories with documented intervention outcomes are not — they cannot be retroactively created, bought off a broker, or synthesized to pass clinical review.
How $KTN works
Demand side — institutions
Pharmaceutical companies, longevity researchers, Health-AI developers, insurers and DeSci DAOs must acquire, lock, or burn $KTN to license anonymized cohorts, query the data layer, or train and validate models against it. Four demand tiers range from time-boxed cohort licenses up to priority-access locks.
Supply side — patients (Data-to-Earn)
Patients mint $KTN through verifiable clinical value, never raw activity:
- M1 — Consent: informed consent to share an anonymized longitudinal record.
- M2 — Verified milestone: documented HbA1c reduction or insulin reduction/discontinuation.
- M3 — Longitudinal continuity: capped, sunsetting path for continued high-quality follow-up.
Trust layer
- Zero-knowledge proofs and an on-chain consent registry prove outcomes and data quality without revealing patient identity.
- Differential-private query engine; GDPR-grade compliance posture from day one.
- A Data Ethics Council holds veto power over data use.
Two layers, strictly separated
| Layer | Instrument | Transferable? | Function |
|---|---|---|---|
| Economic | $KTN (ERC-20) | Liquid | Settlement for licenses, staking for query rights, burn sinks, governance |
| Reputation | Ketonia Soulbound Token (KSBT, ERC-5192) | No | Clinical credentials, milestone attestations, data-quality score, governance weight, access tiers |
Why this is defensible
- Supply is capped by biology and time. No competitor can retroactively create five-year metabolic trajectories. New entrants must recruit patients and wait years; Ketonia already holds the asset.
- Demand is non-discretionary. A Health-AI team training a hypoglycemia-prediction model, or a DAO funding an RCT on fasting protocols, needs real outcome data. There is no synthetic substitute that passes clinical review.
- The token is the toll. All institutional access routes through $KTN acquisition, staking, or burn — structural, recurring demand proportional to the commercial value of the data.
- Deflation is mechanical. ≥40% of B2B token revenue is burned by constitutional rule; staking and priority locks remove further float.
Get involved
Researchers & DAOs
Review the litepaper for cohort-licensing tiers, staked query rights and milestone-escrowed joint studies. Propose a cohort on the governance forum.
Patients & community
Ketonia’s clinical platform, wiki and community live at ketonia.life; discussion and governance at the forum.